![]() ![]() Glazer also leads the radiation oncology program at Smilow Cancer Hospital and its network of care centers. His work has led to multiple new clinical trials for cancer at Yale and elsewhere. His lab has developed novel DNA repair inhibitors for cancer therapy and has advanced triplex-forming oligonucleotides for gene editing. He discovered that tumor hypoxia causes genetic instability and that mutations in isocitrate dehydrogenase and related metabolic genes suppress DNA repair in cancers, conferring vulnerability to PARP inhibitors. His research was recognized by the National Cancer Institute of the National Institutes of Health with a prestigious Outstanding Investigator Award of $7 million that supports his efforts to exploit DNA repair for cancer therapy. Glazer researches new strategies for treating cancer and the role of altered DNA repair in tumor progression. Hunter Professor of Therapeutic Radiology and professor of genetics. I am truly honored to welcome these esteemed individuals to the National Academy of Medicine.” Dzau says of Glazer and Omer and the academy’s 98 other newly elected members, “Their expertise will be vital to informing the future of health and medicine for the benefit of us all. ![]() New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. Founded in 1970 as the Institute of Medicine the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. Omer, MBBS, MPH, PhD have been elected to the prestigious National Academy of Medicine, the academy announced today.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |